Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-individual Open-label Multicenter Comparison Study of Magnetic Resonance Angiography (MRA) With the Blood Pool Contrast Agent Vasovist® and a Conventional Extracellular Contrast Agent With Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients With Peripheral Artery Disease

NCT00296855 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00296855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00296855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-individual Open-label Multicenter Comparison Study of Magnetic Resonance Angiography (MRA) With the Blood Pool Contrast Agent Vasovist® and a Conventional Extracellular Contrast Agent With Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients With Peripheral Artery Disease
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
February 28, 2007
Enrollment
261 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular diseases